Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.56 -0.10 (-6.02%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026)

Updated

Cardiol Therapeutics (CRDL) recorded Return on Equity [ROE] of -145.44% in Q2 2026, up 126.56 percentage points from -272.00% a year earlier and up 20.52 percentage points from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Cardiol Therapeutics reported Return on Equity [ROE] of -156.88%, down 18.83 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for three straight years, with a four-year change of -85.51 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -138.05% in FY2024 (-68.26 pp), -69.80% in FY2023 (-23.90 pp), -45.90% in FY2022 (+25.48 pp) and -71.38% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Equity [ROE] since Q1 2024.
  • On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -53.46 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 126.56 percentage points in Q2 2026, against a drop of 210.44 percentage points in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -165.96% (Q1 2026), -243.36% (Q4 2025) and -327.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Cardiol Therapeutics 166.43 Mn 166.43 Mn - -145.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -145.44%
Mar 31, 2026 -165.96%
Dec 31, 2025 -243.36%
Sep 30, 2025 -327.76%
Jun 30, 2025 -272.00%
Mar 31, 2025 -188.83%
Dec 31, 2024 -225.20%
Sep 30, 2024 -287.94%
Jun 30, 2024 -170.67%
Mar 31, 2024 -118.76%
Dec 31, 2023 -87.93%
Sep 30, 2023 -77.50%
Jun 30, 2023 -82.41%
Mar 31, 2023 -79.15%
Dec 31, 2022 -73.99%
Sep 30, 2022 -62.71%
Jun 30, 2022 -53.11%
Mar 31, 2022 -44.67%
Dec 31, 2021 -60.11%
Sep 30, 2021 -59.50%
API Access

Cardiol Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY